Replies to post #206140 on Biotech Values

[Whalatane]

Thx Dew ... AMGN's data didn't look that strong ...reduction of 3.2 days - 3.7 days vs placebo reduction at 1.8 days .
Baseline of an average of 8.3 migraine days per month .

So my " non medical lay mans " question is ....wouldn't patients prefer the oral Lasmiditan ( CLCD ) for the 8.3 migraine days then a sub Q injection , monthly to reduce those days from 8 days to 3-4 days ...especially since Lasmiditan has a fast on set of action ?

Kiwi